TY - JOUR. T1 - Hand-carried Ultrasound Performed by Hospitalists. T2 - Does It Improve the Cardiac Physical Examination?. AU - Martin, L. David. AU - Howell, Eric E.. AU - Ziegelstein, Roy C.. AU - Martire, Carol. AU - Whiting-OKeefe, Quinn E.. AU - Shapiro, Edward P.. AU - Hellmann, David B.. PY - 2009/1. Y1 - 2009/1. N2 - Objective: The traditional physical examination of the heart is relatively inaccurate. There is little information regarding whether cardiac hand-carried ultrasound performed by noncardiologists adds to the accuracy of physical examinations. The purpose of this study was to determine whether hand-carried ultrasound can add to the accuracy of hospitalists cardiac physical examinations. Methods: During a focused training program in hand-carried echocardiography, 10 hospitalists performed cardiac examinations of 354 general medical inpatients first by physical examination and then by hand-carried ultrasound. Eligible inpatients included those for whom a conventional hospital ...
This book is a rich source of information on point-of-care (POC) tests for the diagnosis and treatment of severe hemorrhage, including thromboelastography, thromboelastometry, heparin monitoring systems, and platelet function analyzers (Multiplate, PFA-100, VerifyNow, etc.). The opening chapters focus on the pathophysiology of coagulation and the general characteristics of POC devices. The relevance of POC tests in specific scenarios is then carefully explained, with guidance on their use in contexts including trauma, cardiovascular surgery, ECMO, liver surgery, postpartum hemorrhage, and disorders of hemostasis in the critically ill. An individual chapter is devoted to practical issues when applying POC tests, and the book closes by presenting a set of informative clinical cases. As POC devices gain increasing popularity as bedside diagnostic tools in different clinical settings, it is important for practitioners to understand their role and value. Point-of-Care Tests for Severe Hemorrhage will ...
Most point-of-care tests require a tiny sample of blood the fingertip is pricked with a lancet. Other oraquick require oral fluid an absorbent pad is swabbed around the outer gums, adjacent to the teeth.. Pepex price rapid tests detect HIV antibodies. These source persist for life. In contrast, the recommended laboratory tests also detect p24 antigen, a protein contained in HIVs viral core that can be detected sooner than antibodies.. The accuracy of point-of-care tests is not always equal to those of laboratory tests, oraquick six weeks, especially in relation to recent infection.. This is for two main reasons:. Other rapid tests, based on older technology, may have longer window periods than this. Rapid tests can be performed by staff with limited laboratory training. However, reading the test result relies on subjective interpretation, and when the result is borderline, experienced staff give more consistently accurate results.. In a setting with low prevalence weeks HIV, staff may not see ...
[105 Pages Report] Check for Discount on Global Point-Of-Care Devices Market Professional Survey Report 2016 report by QYResearch Group. Notes: Production, means the output of Point-Of-Care Devices...
TY - JOUR. T1 - Evaluation of the Xpert HCV Viral Load Finger-Stick point-of-care assay. AU - Lamoury, Francois M. J.. AU - Bajis, Sahar. AU - Hajarizadeh, Behzad. AU - Marshall, Alison D.. AU - Martinello, Marianne. AU - Ivanova, Elena. AU - Catlett, Beth. AU - Mowat, Yasmin. AU - Marks, Philippa. AU - Amin, Janaki. AU - Smith, Julie. AU - Ezard, Nadine. AU - Cock, Victoria. AU - Hayllar, Jeremy. AU - Persing, David H.. AU - Kleman, Marika. AU - Cunningham, Philip. AU - Dore, Gregory J.. AU - Applegate, Tanya L.. AU - Grebely, Jason. AU - LiveRLife Study Group. PY - 2018/5/25. Y1 - 2018/5/25. N2 - Point-of-care hepatitis C virus (HCV) RNA testing is advantageous, enabling diagnosis of active infection in a single visit. This study evaluated the sensitivity and specificity of the Xpert HCV Viral Load Finger-Stick assay (Xpert HCV VL FS) for HCV RNA detection (finger-stick) and the Xpert HCV Viral Load assay (plasma) compared with the Abbott RealTime HCV Viral Load assay by venepuncture. Plasma ...
Objective: To determine the uptake of current antenatal HIV testing, the prevalence of risk factors for HIV in pregnant women and the acceptability of the Rapid Point-of-Care HIV Test (RPOCT) amongst pregnant women and their midwives. Design: A retrospective review of 717 notes to determine current HIV screening practices and a cross- sectional survey using a self-completed questionnaire for pregnant women and midwives. Setting: The Antenatal Clinic (ANC) and Postnatal wards (PNW) at a University teaching hospital in the West Midlands. Participants: 486 women attending the ANC or admitted to the PNW during a fortnight in May-June 2006 and 72 midwives on the delivery ward completed a second questionnaire. Results: From the questionnaire, it was determined that 90.4% of those offered the standard HIV test accepted it, with 7.2% having at least 1 risk factor for HIV. Of the decliners, over half perceived themselves not at risk. 85.2% would accept the rapid test, including 35.6% of those who ...
This is a diagnostic validation study for a combined Syphilis/HIV test made by MBio Diagnostics, Inc (MBio, Boulder, CO, USA). Although the MBio Syphilis/HIV diagnostic platform is designed for use at point of care (POC), it is made to provide similar performance as reference standards. Diagnosing HIV and syphilis accurately with a single POC test will save time for clinic health workers and technicians, reduce loss-to follow-up caused by lengthy delays for lab-based tests, and save costs by eliminating the need for multiple tests. For this study, the sensitivity and specificity of the MBio HIV/Syphilis Serology System point-of-care diagnostic test will be determined using reference tests performed under controlled laboratory conditions. For this, clients receiving routine care in the ANCs at the New Nyanza Provincial General Hospital (NNPGH) and Kisumu District Hospital (KDH) will be consented to provide blood for the proposed study. Study volunteers will receive HIV and syphilis rapid tests ...
TY - JOUR. T1 - Feasibility of a point-of-care test based on quantum dots with a mobile phone reader for detection of antibody responses. AU - Cysticercosis Working Group in Peru. AU - Lee, Chan. AU - Noh, John. AU - ONeal, Seth E.. AU - Gonzalez, Armando E.. AU - Garcia, Hector H.. AU - Handali, Sukwan. PY - 2019/10/1. Y1 - 2019/10/1. N2 - We developed a novel and portable fluorescent sensor that integrates a lateral flow assay with a quantum dot (Qdots) label and a mobile phone reader for detection of specific antibodies in human serum. We evaluated the utility of this assay to test for antibodies to the Taenia solium rT24H antigen. It was a retrospective study by examining 112 positive human sera from patients with neurocysticercosis (NCC) including samples from patients with single viable cyst (n = 18), two or more viable cysts (n = 71), and subarachnoid (racemose) cysts (n = 23). These samples were collected from previous study subjects in Lima, Peru under an approved study protocol in ...
Point-of-care tests (POCTs) offer considerable potential for improving clinical and public health management of COVID-19 by providing timely information to guide decision-making, but data on real-world performance are in short supply. Besides SARS-CoV-2-specific tests, there is growing interest in the role of surrogate (non-specific) tests such as FebriDx, a biochemical POCT which can be used to distinguish viral from bacterial infection in patients with influenza-like illnesses. This short report assesses what is currently known about FebriDx performance across settings and populations by comparison with some of the more intensively evaluated SARS-CoV-2-specific POCTs. While FebriDx shows some potential in supporting triage for early-stage infection in acute care settings, this is dependent on SARS-CoV-2 being the most likely cause for influenza-like illnesses, with reduction in discriminatory power when COVID-19 case numbers are low, and when co-circulating viral respiratory infections become ...
MEDFORD, N.Y., Sept. 26, 2016-- Chembio Diagnostics, Inc., a leader in point-of-care diagnostic tests for infectious diseases, today announced that the Company has been awarded a grant from the United States Department of Agriculture to develop a POC diagnostic test for bovine tuberculosis. The $600,000 grant is managed by the Small Business Innovation Research...
A new study provides a first step toward the development of an inexpensive point-of-care diagnostic test to assess the presence of known risk factors for preterm birth in resource-poor areas. The study found that measuring levels of TIMP-1 and D-lactic acid in vaginal secretions may be a non-invasive, cost-effective way to assess the risk for preterm birth due to a short cervix and microbiome composition. The research is published in mBio, an open-access journal of the American Society for Microbiology.. We have found that there are components in the vagina, proteins and bacteria, that can be used to identify women who are at elevated risk for preterm birth, said Larry Forney, PhD, a member of the Institute of Bioinformatics and Evolutionary Studies and Distinguished University Professor in the Department of Biological Sciences, University of Idaho, Moscow, Idaho. There is a need to have a cost-effective diagnostic that can be used to identify women who are at risk for a preterm birth, so ...
Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapy Steven D Reid, Sarah J Fidler, Graham S Cooke Department of Infectious Diseases, St Mary's Hospital, Imperial College London, London, UK Abstract: It is now around 30 years since the discovery of HIV, the virus that causes AIDS. More than 70 million people have been infected in that time and around 35 million have died. The majority of those currently living with HIV/AIDS are in low- and middle-income countries, with sub-Saharan Africa bearing a disproportionate burden of the global disease. In high-income countries, the introduction of antiretroviral therapy (ART) has drastically reduced the morbidity and mortality associated with HIV. Patients on ART are now predicted to have near-normal life expectancy and the role of treatment is increasingly recognized in preventing new infections. In low- and middle-income countries, treatment is now more widely available and around half of those who need ART are
The details of bibliography - The potential impact of new generation molecular point-of-care tests on gonorrhoea and chlamydia in a setting of high endemic prevalence
Clozapine remain the drug of choice for treatment resistant schizophrenia and up to 60% of patients not responding to other antipsychotics will respond to clozapine. However, the use of clozapine is restricted due to the risk of agranulocytosis and consequently the need for mandatory hematological monitoring. CHEMPAQ XBC is a point-of-care device that can be used in patients home and analyze WBC and granulocytes by a single capillary blood drop. This study aims to investigate whether this new procedure increases the acceptability of ...
Background Rapid point-of-care (POC) assessment of hemostasis is certainly clinically important in patients with a variety of coagulation factor and platelet defects who have bleeding disorders. distinguishing among coagulation disorders as compared to conventional screening coagulation tests. Moreover, the ClotChip r,max parameter detected platelet function inhibition induced by aspirin and exhibited strong positive correlation with light transmission aggregometry. Conclusions This study demonstrates that ClotChip assesses multiple aspects of the hemostatic process in whole blood on a single disposable cartridge, highlighting its potential as a POC platform for rapid, comprehensive hemostatic analysis. Introduction Early identification of hemostatic dysregulation and bleeding risk is important in the management of patients who are critically ill, severely injured, or on antiplatelet/anticoagulation therapies [1]. order Iressa Conventional laboratory-structured coagulation exams are time-eating, ...
Competitive Analysis:. The report presents business mechanisms and growth-oriented approaches used by leading companies in this Point-of-Care Testing (POCT) Devices market. The report highlights numerous strategic initiatives, such as new deals and partnerships, mergers and acquisitions, joint ventures, product launches, and technology upgrades, that have been carried out by leading market players to gain strong market positions. Therefore, this section includes company profiles of the key players, cumulative total revenue, product sales, profit margins, product prices, sales and distribution channels, and industry analysis.. The report covers the following key players in the Point-of-Care Testing (POCT) Devices Market:. Segmentation of Point-of-Care Testing (POCT) Devices Market:. The Point-of-Care Testing (POCT) Devices market report has been segmented into Types, Applications, and End-users. It provides the market share of each segment participating in the Point-of-Care Testing (POCT) Devices ...
This project is part of the EDCTP2 programme supported by the European Union. Abstract. Tuberculosis kills ~1.4 million people annually and is a leading cause of death in sub-Saharan Africa. Sensitive and rapid point-of-care tests are expected to substantially reduce TB incidence and mortality, however, until recently, tests that meet these criteria are yet to become available. We propose a package of novel diagnostic studies to build local capacity and evaluate the feasibility, accuracy, and effectiveness of new, ultra-sensitive point-of-care tests for TB and drug-resistance in our high-burden, high HIV setting of Cape Town, South Africa.. Firstly, we will evaluate the accuracy and impact of Xpert Ultra (using the Omni system) and AlereQ TB testing for pulmonary TB at the point-of-care in clinics (n=360 patients). These tests, which likely have sensitivity equivalent to a culture, may have utility in patients with few or no symptoms (~1 in 5 TB cases are missed by screening algorithms). We will ...
This project is part of the EDCTP2 programme supported by the European Union. Abstract. Tuberculosis kills ~1.4 million people annually and is a leading cause of death in sub-Saharan Africa. Sensitive and rapid point-of-care tests are expected to substantially reduce TB incidence and mortality, however, until recently, tests that meet these criteria are yet to become available. We propose a package of novel diagnostic studies to build local capacity and evaluate the feasibility, accuracy, and effectiveness of new, ultra-sensitive point-of-care tests for TB and drug-resistance in our high-burden, high HIV setting of Cape Town, South Africa.. Firstly, we will evaluate the accuracy and impact of Xpert Ultra (using the Omni system) and AlereQ TB testing for pulmonary TB at the point-of-care in clinics (n=360 patients). These tests, which likely have sensitivity equivalent to a culture, may have utility in patients with few or no symptoms (~1 in 5 TB cases are missed by screening algorithms). We will ...
San Francisco, July 11, 2016-- The global Point-of-Care Diagnostics market is anticipated to reach USD 20.9 billion by 2024, according to a new report by Grand View Research, Inc. Rise in the R&D funding and research activities amongst the market players in order to introduce novel POC tests and devices for ease of disease detection and monitoring is expected...
SARASOTA FL (PRWEB) October 12 2017 RPS Diagnostics Inc. (RPS®) today announces publication of a United States multicenter prospective clinical study that dem,Clinical,Study,Demonstrates,that,RPS,Diagnostics,FebriDx,Rapid,Point-of-Care,Blood,Test,Can,Accurately,Distinguish,Between,Acute,Bacterial,and,Viral,Respiratory,Infection,biological,advanced biology technology,biology laboratory technology,biology device technology,latest biology technology
Background: Due to the unpredictable burden of pandemic influenza, the best strategy to manage testing, such as rapid or polymerase chain reaction (PCR), and antiviral medications for patients who present with influenza-like illness (ILI) is unknown. Methodology/Principal Findings: We developed a set of computer simulation models to evaluate the potential economic value of seven strategies under seasonal and pandemic influenza conditions: (1) using clinical judgment alone to guide antiviral use, (2) using PCR to determine whether to initiate antivirals, (3) using a rapid (point-of-care) test to determine antiviral use, (4) using a combination of a point-of-care test and clinical judgment, (5) using clinical judgment and confirming the diagnosis with PCR testing, (6) treating all with antivirals, and (7) not treating anyone with antivirals. For healthy younger adults (,65 years old) presenting with ILI in a seasonal influenza scenario, strategies were only cost-effective from the societal ...
To measure CD4 T-cells, the prime indicator of HIV disease progression, a new point-of-care test can expedite the process leading from HIV diagnosis to antiretroviral therapy (ART) and improve clinical outcomes.
This document contains guidelines for performance of point-of-care blood glucose meter systems that stress quality control, training, and administrative responsibility. CLSI Approved Guideline.
The skin, soft tissue, and most parts of the musculoskeletal system are relatively superficial anatomical structures and ideal targets for ultrasound examination in the emergency departments. Soft tissue and musculoskeletal ultrasound applications are relatively underused compared to traditional emergency applications, such as trauma, abdominal aortic aneurysm, and chest and cardiovascular systems. It is important to have knowledge about sonoanatomy and landmarks within the skin, soft tissue, and musculoskeletal systems. Portable machines equipped with high-resolution transducers are now available to fulfill this field of applications in many emergency departments. After needling practice, emergency physicians can not only diagnose and identify pathological findings but also provide interventional procedures and treatments. In this review, we will introduce point-of-care ultrasound (POCUS) applications regarding the soft tissue and musculoskeletal systems: soft tissue infections, joint effusions,
Author(s): Ogle, Kathleen; Mandoorah, Sohaib; Fellin, Matthew; Shokoohi, Hamid; Probasco, William; Boniface, Keith | Abstract: Musculoskeletal complaints are one cornerstone of urgent issues for which orthopedic and emergency physicians provide care. Ultrasound can be a useful diagnostic tool to help identify musculoskeletal injuries. We describe a case of bilateral patellar tendon rupture that presented after minor trauma, and had the diagnosis confirmed at the bedside by point-of-care ultrasound.Physicians caring for patients with orthopedic injuries should be familiar with the use of ultrasound to diagnose tendon ruptures.
From battlefield to bedside, these rugged and reliable solutions have ushered in a new era of helping clinicians bring ultrasound to any patient, anywhere, anytime. BOTHELL, Wash., July 20, 2018 - FUJIFILM Sonosite Inc., specialists in developing cutting-edge, portable and point-of-care ultrasound solutions, today announced that the company is celebrating the inception of
A 16-year-old male presented with three months of palpitations at rest, fatigue, and episodic pre-syncope; his paternal grandfather died following presumed premature myocardial infarction at age 30. He was seen and discharged one week previously at an outside emergency department (ED). He followed up with his pediatrician and was promptly referred to our pediatric ED for evaluation given his risk factors. Pertinent vitals on arrival were pulse 110, blood pressure 129/66, and oxygen saturation 97% on room air. His exam was remarkable for a left upper sternal border 2/6 holosystolic murmur with radiation to apex. In addition, the patient had a chest radiograph (Figure), a nonspecific but abnormal EKG, and a point-of-care ultrasound (POCUS) of the heart performed.. ...
EDE (Emergency Department Echo) Point-of-Care Ultrasound is the most highly rated introductory ultrasound course in North America.
INTRODUCTION Point-of-care ultrasound (POCUS) of the kidney and bladder are among the most commonly performed POCUS scans in rural New Zealand (NZ). AIM To determine the quality, safety and effect on patient care of POCUS of the kidney and bladder in rural NZ. METHODS Overall, 28 doctors in six NZ r …
As perioperative anesthesiologists, we work in a fast-paced environment where we often have to make critical decisions for patients with rapidly evolving pathology and clinical scenarios. These potentially life-saving interventions are made without the luxury of time for a complete assessment or ordering of advanced imaging. Therefore, emergencies inherently result in gaps in clinical evidence and the potential for suboptimal management.. The idiom seeing is believing means that only physical or concrete (i.e., visible) evidence is convincing. In these emergent and critical scenarios, point-of-care ultrasound (PoCUS) has proven to be a powerful tool to obtain concrete evidence to either confirm or rule out severe and potentially life threatening conditions.. ...
Tenth Annual Ultrasound-Guided Cadaver Course for Regional Anesthesia and Point-of-Care Ultrasound: 1) In the Advanced Neuraxial track, interfascial
/PRNewswire/ -- (Booth # 641) - FUJIFILM SonoSite, Inc., specialists in developing cutting-edge, point-of-care ultrasound (POCUS), and part of the greater...
Point-of-care diagnostics, IBM research. Microchip used for diagnostics (lab on a chip) as developed by IBM scientists Luc Gervais and Emmanuel Delamarche at IBM Research-Zurich, Switzerland. This IBM system uses an innovative silicon chip and can test for many diseases, including cardiovascular disease. It can also test for chemical and biological hazards and monitor medicinal therapies. The microchip measures 1 by 5 centimetres. Photographed in September 2009. - Stock Image C022/8413
Framingham, MA - September 18, 2018. The National Institute of Allergy and Infectious Diseases, an agency of the National Institutes of Health (NIH), has awarded a two-year, $599,316 SBIR grant to Kephera Diagnostics to develop a new test for Chagas disease, the company announced today. Under the SBIR grant program, this Phase I grant is aimed at demonstrating feasibility of the test, following which the company will be eligible to apply for second phase funding to complete product development.. Chagas, a trypanosomal disease transmitted by an insect which is endemic throughout most of Latin America, is the most prevalent parasitic disease in the western hemisphere. Chagas infection can lead to a range of serious complications including fatal cardiomyopathy. The disease is estimated to account for economic losses over $7 billion/year, and has been named as a top public health priority by the World Health Organization. Existing tests have not proven as sensitive and specific as required for an ...
DUBLIN, July 19, 2016 /PRNewswire/ -- Point-of-Care Diagnostics Market Worth USD 36.96 Billion by 2021 - Increasing Inclination Towards Home Healthcare -...
Background: Measurement of glycosylated hemoglobin (HbA1c) levels is standard of care in assessment of glycemic control among diabetes mellitus patients. Traditional high performance liquid chromatography (HPLC) based tests are expensive, need specialized equipment, and have a longer turn-around-time. Point-of-care tests to estimate HbA1c levels are now commercially available but with only limited studies from developed nations. We performed this study to understand diagnostic accuracy of two commercially available HbA1c point-of-care test. Methods: The study was conducted in an urban and a rural outpatient clinic in central India. We compared HbA1c estimated from two index tests (Hemocue Hb501, Sweden; SD Biosensor, South Korea) from capillary blood samples and compared it with HPLC, as a reference standard in an independent and a blinded manner. We estimated diagnostic accuracy of the index tests as compared to the reference standard. Results: The area under Reciever Operating Curve (ROC) for
Abbott (formally Alere) diagnostics and point of care solutions for better information and better decisions. Find out more about our best-in-class products.
Alere diagnostics and point of care solutions for better information and better decisions. Find out more about our best-in-class products.
Background:. Volatile organic compounds (VOCs) in breath have been reported as biomarkers of breast cancer and abnormal mammograms, apparently resulting from increased oxidative stress and cytochrome p450 induction. We evaluated a six-minute point-of-care breath VOC assay at three breast cancer screening centers in USA and the Netherlands.. Methods:. 244 women had a screening mammogram (93/37 normal/abnormal) or a breast biopsy (cancer/no cancer 35/79). A mobile point-of-care system collected and concentrated breath and air VOCs for analysis with gas chromatography and surface acoustic wave detection. Chromatograms were segmented into a time series of alveolar gradients (breath minus room air). Segmental alveolar gradients were ranked as candidate biomarkers by C-statistic value (area under curve [AUC] of receiver operating characteristic [ROC] curve). Multivariate predictive algorithms were constructed employing significant biomarkers identified with multiple Monte Carlo simulations and ...
This thesis presents technological advancements in microfluidics. The overall goals of the work are to develop new miniaturized tests for point-of-care diagnostics and robust super-lubricating surfaces for friction reduction. To achieve these goals, novel materials, surfaces and manufacturing methods in microfluidics have been developed.. Point-of-care diagnostic tests are portable miniaturized instruments that downscale and automate medical tests previously performed in the central laboratories of hospitals. The instruments are used in the doctors office, in the emergency room or at home as self-tests. By bringing the analysis closer to the patient, the likelihood of an accurate diagnosis, or a quick therapy adjustment is increased. Already today, there are point-of-care tests available on the market, for example blood glucose tests, rapid streptococcus tests and pregnancy tests. However, for more advanced diagnostic tests, such as DNA-tests or antibody analysis, integration of microfluidic ...
High prevalence rates of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) have been reported in Aboriginal people in remote and regional areas of Australia for well over two decades, and repeat positivity rates are high. To interrupt disease transmission and reduce the risk of complications, early diagnosis and treatment is important. However in many remote and regional areas there are long delays between testing for these curable sexually transmissible infections and providing treatment, due to both physical distance from laboratories and difficulties when recalling patients for subsequent management once results are available. Point-of-care (POC) tests have the potential to provide more timely diagnosis, to increase treatment and contact tracing, and in turn reduce CT and NG infection rates. TTANGO (Test, Treat, ANd GO) is a cross-over cluster randomised controlled trial in 12 regional or remote Australian health services, which predominantly provide clinical services to Aboriginal people.
Dual antiplatelet therapy is important treatment modality across the spectrum of coronary artery disease manifestations. However, a significant number of patients do not have a completely effective re
Dr. Rose and his team are developing an innovative microfluidics-based platform for point-of-care molecular detection of a broad range of respiratory pathogens. Over 220 million people worldwide suffer from respiratory infections each year. This number is expected to increase by 10-20% annually over the next decade, creating demand for tests to differentiate between infectious diseases with similar symptoms, especially in low-resource settings. The proposed product, under development by Micronics, Inc. (Redmond, WA), is a microfluidics cartridge that will operate in a compact battery-operated instrument, permitting diagnostic assays to be performed rapidly in low-resource settings at minimal cost. All reagents for specimen processing, PCR-based target amplification, detection, and read-out are integrated into a disposable cartridge. A unique feature is Dr. Roses CODEHOP PCR primer technology, which permits broad detection of related viruses in a single assay. The goal of the proposed work is to ...
Global Point-of-Care (POC) Testing Devices Market Report 2020 has complete details about market of Point-of-Care (POC) Testing Devices industry, Point-of-Care (POC) Testing Devices analysis and current trends. Global Point-of-Care (POC) Testing Devices Market Report 2020 Full Report: 2350 USD Multi License (Section): 4700 USD Section Price: As below Page: 115 Chart and Figure: 124 Publisher: BisReport Delivery Time: 24 hour At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with CO.
A report from Progressive Markets says that the global point-of-care diagnostic market is expected to grow at a CAGR of 9.4% from 2017 to 2025. Point-of-care (POC) or bedside testing is now much easier with reliable point-of-care diagnostic devices available in the market. Advanced devices such as point-of-care drug test cups and handheld analyzers can [...] ...
The results of HPV detection in 550 cervical samples by cervical cytology were compared with the sequencing analysis and HPV genotyping 9G membrane test. The HPV genotyping 9G membrane test can efficiently identify and discriminate five HR-HPV genotypes. The 100% identical results of HPV genotyping 9G membrane tests with the sequencing results in 550 clinical samples ensure its wide clinical applicability. The simple handling steps and the portable scanning device make the HPV genotyping 9G membrane test applicable in point-of-care settings. Moreover, the HPV genotyping 9G membrane test allows one to obtain final results in 30 min at 25 °C by simply loading the hybridization and washing solution and scanning the membranes without any drying steps or special handling. The clinical sensitivity and specificity of the HPV genotyping 9G membrane test was found to be 100%, which is much higher than cervical cytology.
Evidence reviews synthesize the available research on a specific HIV or hepatitis C prevention, testing, treatment, care or support approach.. Disclosure programming - This review examines the evidence related to HIV disclosure and focuses on disclosure to sexual partners, family and friends.. Health Navigation - A review of the evidence to support the impact of health navigation on screening, testing and diagnosis, care, and treatment.. Does multidisciplinary care improve health outcomes among people living with HIV and/or HCV? - A review of the scientific literature found that people living with HIV and/or hepatitis C who access the services of a multidisciplinary care team are more likely to achieve optimal health outcomes, and in the case of hepatitis C, a cure.. Rapid point-of-care HIV testing - A review of the evidence to support the impact of rapid point-of-care testing on HIV testing uptake, acceptability, receipt of results and other outcomes.. HIV point-of-care testing in Canadian ...
This sample first pathway, which enabled the real-life impact of rapid and POC test introduction into our SHC, was highly acceptable, demonstrated by ,90% of those providing feedback in favour of giving samples on arrival and receiving results in the same clinical visit.. This is the first report of absolute times waited for the CT/NG GeneXpert, as opposed to willingness to wait.16 ,23 Results from microscopy and non-NAAT POCTs were all available by time of consultation and compared with the standard clinical pathway, resulted in increased numbers of diagnoses at first visit, compared with routine microscopy alone, leading to an increased number of treatments given. This had potential benefits of reducing duration of infection and risk of transmission to sexual partners.. In stark contrast, CT/NG results were available in time for only a fifth of patients, with GeneXpert processing times too long to impact on the majority of patients clinical care, a finding consistent with previous ...
INTRODUCTION: Patients on intravenous heparin require regular activated partial thromboplastin time monitoring. Laboratory-based activated partial thromboplastin time assays necessitate a delay between blood sampling and dose adjustment. Point-of-care testing could permit immediate dose adjustments, potentially enabling tighter control of anticoagulation. AIM: To assess equivalence of activated partial thromboplastin time measured by conventional laboratory assay and by a novel proprietary point-of-care testing system (Hemochron Response, ITC, Thoratec Corporation, Edison, NJ) among surgical ward patients on intravenous heparin. METHODS: A total of 39 blood samples from patients on intravenous heparin were tested with both laboratory and point-of-care assays. Assay equivalence was assessed by Bland-Altman analysis. Results. Point-of-care measurements exceeded laboratory activated partial thromboplastin time by a mean of 15 seconds (standard deviation 19). In 19 cases (49%), the point-of-care measurement
Point-of-Care Diagnostics Microfluidics Lab-on-a-Chip Global Health Viral Diseases Infectious Disease Biosensors Biodetection Biosecurity Speaker Biography
Point-of-Care Diagnostics Microfluidics Lab-on-a-Chip Global Health Viral Diseases Infectious Disease Biosensors Biodetection Biosecurity
DE KOCK, S H; OTTO, S F y JOUBERT, G. The feasibility of determining the position of an endotracheal tube in neonates by using bedside ultrasonography compared with chest radiographs. S. Afr. j. child health [online]. 2015, vol.9, n.1, pp.3-5. ISSN 1999-7671.. BACKGROUND: Neonates in our neonatal intensive care unit (NICU) receive a large amount of radiation with X-rays (XRs) being done daily, even more often with reintubation, repositioning of endotracheal tubes (ETTs) and confirmation thereof, which has been our NICU policy for many yearsOBJECTIVE: To investigate the feasibility of determining the position of ETTs in neonates by using bedside ultrasonography (BUS), and to compare the results with those obtained from chest XR (CXR) findingsMETHODS: A prospective, cross-sectional study was done on intubated neonates in the NICU at Universitas Academic Hospital, Bloemfontein, to determine the position of ETTs by using BUSRESULTS: Thirty intubated patients included in this study had a median age ...
China Med-Du-S8exp Portable Echocardiography Color Doppler Ultrasound Machine, Find details about China High Class 4D Color Doppler, Ultrasound from Med-Du-S8exp Portable Echocardiography Color Doppler Ultrasound Machine - Guangzhou Med Equipment Co., Ltd.
by Jill Scoggins, HSC communications and marketing - last modified Oct 09, 2014 09:48 AM. A third-year medical student at the University of Louisville has led a group of researchers from five universities in determining that bedside ultrasound is cost-effective as well.. With colleagues from Columbia University, Northwestern University, George Washington University, Jefferson Medical College and UofL, Alexander Thai will present results from the study, Cost Effectiveness of Implementation of Point-of-Care Ultrasound in a Pediatric Emergency Department, at the American Academy of Pediatrics National Conference and Exhibition in San Diego.. Thai will make his presentation at the pre-conference Section on Emergency Medicine on Friday, Oct. 10, at 3:45 p.m. PDT.. The clinical value of bedside ultrasound - known as point-of-care ultrasound or POCUS - has long been established. What Thai and his colleagues, including In K. Kim, M.D., of UofLs Department of Pediatrics Emergency Medicine Division, ...
1 Peeling, R., Holmes, K., Mabey, D., Ronald, A. (2006). Rapid tests for sexually transmitted infections (STIs): the way forward. Sexually Transmitted Infections, 82 Suppl 5, v1-6.. 2 Ministerial Advisory Committee on AIDS Sexual Health and Hepatitis. (2011). National HIV Testing Policy: Commonwealth Government Department of Health and Ageing, 2011.. 3 Guidasci, T. (2009). Fourth generation point of care HIV screening. Clinical Laboratory International, 33(3), 26-28.. 4 Therapeutic Goods Administration. (2012, 17 December). Alere Determine HIV 1/2 Ag/Ab Combo test: information for consumers. Australian Government Department of Health and Ageing (DoHA). Retrieved from: www.tga.gov.au. 5 Prestage, G., Brown, G., Keen, P. (2012). Barriers to HIV testing among Australian gay men. Sexual Health, 9(5), 453-58.. 6 Conway, D., Holt, M., McNulty, A., Couldwell, D., Smith, D., Davies, S, et al. (2013). Field performance of the Alere Determine HIV Combo assay in a large Australian multicentre study in a ...
OjoGel technology may allow for faster identification of serious eye injuries, Labriola said. With a rapid point-of-care device such as this, anyone in an emergency department could perform a test and know within minutes if the patient needs urgent surgery to save their vision.. Ascorbic acid, also known as vitamin C, is found in high concentrations in the fluid inside the eye, called aqueous humor, but normally has very low concentration in tears.. Deep damage to the cornea from trauma or incisional surgery releases aqueous humor into the tear film, which increases the concentration of ascorbic acid in tears to a measurably higher level than that found in normal eyes, said Pan, who is also affiliated with the Beckman Institute for Advanced Science and Technology at Illinois. OjoGel offers a unique biosensing technique that provides an effective and simple method for testing ascorbic acid in a point-of-care delivery system, Pan added.. A tiny teardrop is all thats needed to cause a ...
TY - JOUR. T1 - Hand-carried cardiac ultrasound (HCU) device. T2 - Recommendations regarding new technology. A report from the echocardiography task force on new technology of the nomenclature and standards committee of the American Society of Echocardiography. AU - Seward, James B.. AU - Douglas, Pamela S.. AU - Erbel, Raimund. AU - Kerber, Richard H.. AU - Kronzon, Itzhak. AU - Rakowski, Harry. AU - Sahn, L. David J.. AU - Sisk, Eric J.. AU - Tajik, A. Jamil. AU - Wann, Samuel. N1 - Copyright: Copyright 2017 Elsevier B.V., All rights reserved.. PY - 2002/4. Y1 - 2002/4. N2 - The newest introduction to echocardiography is a hand-carried ultrasound (HCU) device. It is a small echocardiographic machine that typically weighs less than 6 lb and can obtain echocardiographic images and data. However, neither the device nor the context of the examination fulfills the criteria for a comprehensive or complete echocardiographic examination. The American Society of Echocardiography believes that HCU will ...
The current situation in our neonatal intensive care unit (NICU) at Universitas Academic Hospital, Bloemfontein, is that all neonates undergo a daily routine X-ray (XR) (either chest or abdominal, or both). Those neonates who are intubated are X-rayed more often, for example, with reintubation, repositioning of endotracheal tubes (ETTs) or when deterioration of their condition is noted. This has been our NICU policy for many years. Consequently, neonates are exposed to high levels of radiation, which should be reduced where possible.. A literature search suggested that a study to determine the position of an ETT using bedside ultrasonography (BUS) would be feasible and possible. Several studies have confirmed that BUS can accurately determine the placing of ETTs in a paediatric ICU setting.[1-3] Ultrasound (US) and chest radiography agreed on ETT placement in 83% of cases, with US having a sensitivity of 91% and a specificity of 50%.[4] Hosseini et al.[5] used right subcostal US with good ...
The patient was admitted to the obstetric service and started on broad-spectrum antibiotics for incomplete septic abortion. She underwent a vacuum-assisted dilation and curettage with removal of uterine contents. Surgical pathology revealed degenerating and focal necrotic chorionic villi consistent with intra-uterine pregnancy. While rare in developed countries, septic abortion is a life-threatening infection of the placenta and fetus of a previable pregnancy typically associated with unsafe abortion practices.1 Diagnosis is made clinically and confirmed by ultrasound, computed tomography or magnetic resonance imaging that can show an enlarged uterus with hemorrhage, retained intrauterine material, free fluid, abscess formation and/or air. 2 Intrauterine air is theorized to arise from gas-forming organisms or secondary to perforation from unsafe abortion practices. The ultrasonographic finding of air in the uterus must be recognized by the emergency physician in order to expedite ED and ...
Emergency Medicine residents at CHUK in Kigali, Rwanda experienced the glory of friendly competition in Point of Care Ultrasound in the first ever edition of Pass and Play. As a visiting fellow working with PURE, I had the opportunity to lecture to the residency during conference days every Wednesday. Instead of image review, I created a competition for the residents inspired by similar competitions in the US. A cross between jeopardy and plain old pimping, the residents divided into teams by classes and were challenged to cases with ultrasound acquisition and image interpretation. Across the board there was excellent performance, including the 1st year residents who have had quite limited exposure to point of care ultrasound. Despite my attempts to stump the 3rd year residents, they were an unstoppable force. The final jeopardy question was unanticipated by the group since it reverted back to the basics of physics in ultrasound. A senior resident came through at the last moment to explain ...
Cohort 1 enrolled 48 patients, vs. 114 patients for cohort 2. Twelve patients in cohort 1 had a POCUS (25%) vs 89 in cohort 2 (78%) ( p , 0.0001; odds ratio [OR] 0.09 (95% confidence interval [CI] 0.04-0.20). Emergency physician (EP) successful aspiration: 89.1% POCUS vs. 24.5% NUS ( p , 0.0001; OR 25 [95% CI 10-59]). Combined EP/ENT successful aspiration: 99.0% POCUS vs. 80.3% NUS ( p , 0.0001; OR 24 [95% CI 3-193]). ENT consultation:12.9% POCUS vs. 65.6% NUS ( p , 0.0001; OR 0.07 [95% CI 0.03-0.17]). CT usage: 23.8% POCUS vs. 37.7% NUS ( p = 0.07; OR 0.51 [95% CI 0.25-1.02]). Return visits: 3.96% POCUS vs. 18.0% NUS ( p = 0.004; OR 0.18 [95% CI 0.05-0.61]).. ...
Eight hundred forty-five participants were included for analysis; 331 (39%) had a ureteral stone. The global performance of the STONE score was superior to physician gestalt (area under the receiver operating characteristic curve=0.78 [95% confidence interval {CI} 0.74 to 0.81] versus 0.68 [95% CI 0.64 to 0.71]). The prevalence of ureteral stone on CT scan ranged from 14% (95% CI 9% to 19%) to 73% (95% CI 67% to 78%) in the low-, moderate-, and high-score groups. The sensitivity and specificity of a high score were 53% (95% CI 48% to 59%) and 87% (95% CI 84% to 90%), respectively.. ...
Interview with Andrew D. Krahn, M.D.,FHRS, head of the division of cardiology at St. Pauls Hospital, and professor of medicine at the University of British Columbia, and vice president of the Heart Rhythm Society (HRS). He is an expert in long QT syndrome (LQTS) and is involved with the National Long QT Registry. He explains the issues with the drugs being used to treat coronavirus (COVID-19, SARS-CoV-2) patients and why these combined with the cardiac impact of the virus is causing prolonged ECG QT segment prolongation, leading to deadly arrhythmias. COVID-19 can cause myocarditis that causes QT prolongation and the front-line COVID drugs hydroxychloroquine and azithromycin also cause QT prolongation.. The U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication April 23, 2020, reminding doctors there are serious side effects when using hydroxychloroquine and chloroquine in the off-label use to treat COVID-19 patients. This includes potentially life-threatening heart rhythm ...
TY - JOUR. T1 - Assessment of a point-of-care lactate monitor in emergency admissions of adult horses to a referral hospital. AU - Tennent-Brown, Brett S.. AU - Wilkins, Pamela A.. AU - Lindborg, Sue. AU - Russell, Gail. AU - Boston, Raymond C.. N1 - Copyright: Copyright 2008 Elsevier B.V., All rights reserved.. PY - 2007/9. Y1 - 2007/9. N2 - Background: Blood lactate concentration [LAC] is considered a useful indicator of disease severity in horses. Agreement of point-of-care (POC) lactate monitors with laboratory standards has not been established for clinically abnormal horses. Hypothesis: It was hypothesized that results from a POC lactate monitor would be in agreement with a laboratory-based measurement of [LAC]. Animals: The study included adult horses presented for emergency evaluation. Methods: A prospective observational study was performed. [LAC] was measured with whole blood (AWB) and plasma (APL) by means of a POC monitor (Accutrend) and compared with results from whole blood ...
The recent revolution in digital technologies and information processing methods present important opportunities to transform the way optical imaging is performed, particularly toward improving the throughput of microscopes while at the same time reducing their relative cost and complexity. Lensfree computational microscopy is rapidly emerging toward this end, and by discarding lenses and other bulky optical components of conventional imaging systems, and relying on digital computation instead, it can achieve both reflection and transmission mode microscopy over a large field-of-view within compact, cost-effective and mechanically robust architectures. Such high throughput and miniaturized imaging devices can provide a complementary toolset for telemedicine applications and point-of-care diagnostics by facilitating complex and critical tasks such as cytometry and microscopic analysis of e.g., blood smears, Papanicolaou (Pap) tests and tissue samples. In this article, the basics of these lensfree ...
Point-of-care ultrasound (POCUS) systems are becoming a common sight in nephrology departments and renal dialysis clinics, helping clinical staff to evaluate and effectively access the vasculature of dialysis patients. Dr. Jean-Yves Bosc, a nephrologist and vascular doctor working at the nonprofit private health establishment AIDER SANTÉ in the South of France, has been a
Rutgers New Jersey Medical School is pleased to offer a two-day hands-on point-of-care ultrasonography course for clinicians. This course is designed for physicians, physician assistants, and advanced practice nurse practitioners interested in integrating ultrasonography into their clinical practice.. Learners will rotate through SHORT LECTURES, SMALL GROUP IMAGE INTERPRETATION SESSIONS, and HANDS-ON LEARNING with LIVE HUMAN MODELS, PERIPHERAL IV, CENTRAL LINE, & THORACENTESIS task trainers.. The course leaders are nationally recognized experts in the field of point-of-care ultrasonography and regularly teach ultrasonography courses at CHEST.. This activity is approved for 14 AMA PRA Category 1 Credits.. Date: Jan 31, 2020 - 12:00pm - 8:30pm; Feb 1, 2020 - 7:00am - 5: ...
These are the first national hospice/palliative care symptom control performance data to demonstrate improvements in clinical outcomes at a service level as a result of routine data collection and systematic feedback.
Video articles in JoVE about venous thromboembolism include Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis, A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis, Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography, Intravital Microscopy and Thrombus Induction in the Earlobe of a Hairless Mouse, Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis, Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood, The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation.
Ramin Artang, MD, discusses a University of Nebraska Medical Center study aimed at improving monitoring of NOACs. NOACs were initially thought to not require monitoring, however the practice of anticoagulating a patient requires some level of monitoring to ensure therapy is not only safe but is also effective. Evaluating outcomes alone in an anticoagulated patient is insufficient, particularly when the patient is having or could have an adverse event. There are many commercial approaches to monitoring NOACs, with the newest technology being TEG6S. The advantage of TEG6S is primarily that it is a point-of-care assay. With this assay, a clinician can know within 10 minutes whether a patient is in the sub- or supra- therapeutic range with a NOAC drug. , TV Network
Infectious diseases are the leading causes of death around the world. Point-of-care devices using nucleic acid amplification are sensitive enough to diagnose these diseases, however, often require complex and time-intensive sample preparation steps that are not integrated with the detection process. A rapid, sensitive, and integrated sample-to-result diagnostic device will permit disease treatment planning at the point-of-care. Paper-based detection assays are a promising platform to integrate the sample preparation and detection, with minimal infrastructure, equipment, and user involvement. To integrate sample preparation with detection on paper-based assays, timing and delivery of sample fluid flow needs to be controlled. Here we use thermally responsive materials (e.g. wax) to create a micro valve on a nitrocellulose membrane in order to automate fluid flow and minimize user involvement. The ease-of-fabrication, lot-to-lot variability and consistency of the dispensing methods are compared. After
TY - JOUR. T1 - Systematic review on antigens for serodiagnosis of visceral leishmaniasis, with a focus on East Africa. AU - Kühne, Vera. AU - Rezaei, Zahra. AU - Pitzinger, Paul. AU - Büscher, Philippe. N1 - FTX. PY - 2019. Y1 - 2019. N2 - BackgroundAccurate and accessible diagnosis is key for the control of visceral leishmaniasis (VL). Yet, current diagnostic tests for VL have severe limitations: they are invasive or not suitable as point of care (POC) test or their performance is suboptimal in East Africa. We analysed the antigens in the VL serodiagnostics development pipeline to identify shortcomings and to propose strategies in the development of an alternative POC test for VL in East Africa.ObjectivesThe objective of this study was to identify and to analyse all antigens for VL serodiagnosis that have been published before 2018 in order to identify candidates and gaps in the pipeline for a new POC test in East Africa.MethodsA systematic literature search was performed on PubMed for ...
Methods First, an item-reduction analysis of the TULIA (48 gestures) was performed, based on the methods of classical test theory and on a larger sample of patients with stroke (n=133) and matched healthy controls (n=50). Stepwise elimination of items resulted in a set of 12 items, demonstrating high internal consistency (Cronbach alpha=0.92). The six-point scoring method of the TULIA was dichotomised to the score levels pass and fail. In the second part of this study the validity of the AST was assessed prospectively in a new cohort of patients with stroke (n=31) by using the Pearson correlation analysis and binary classification display with the TULIA. ...
BACKGROUND: Salmonella enterica can significantly impact management of animal facilities. Comprehensive screening is essential for effective control in high-risk populations. Availability of reliable point-of-care diagnostic tests would facilitate these efforts. HYPOTHESIS/OBJECTIVES: Compare the ability of commercially available rapid diagnostic assays (2 lateral flow immunoassays [LFIs], DNA hybridization [DNAH], real-time PCR [qPCR]), and culture to detect common serotypes of S. enterica in feces. ANIMALS: n/a. METHODS: In an experimental study, 112 S. enterica isolates were randomly selected from the 10 most common serotypes recovered at a veterinary hospital. Archived isolates were amplified in broth and standardized inocula (100 colony forming units) were incubated with equine feces in tetrathionate broth (TET). Cultures were tested in a blinded fashion by using LFIs, DNAH, qPCR, and culture. RESULTS: The LFIs detected 84% and 67% of isolates, respectively, but reactivity varied among ...
AUTHORS: Kim, Won Ho MD, PhD et al. Anesthesia & Analgesia: May, 2017. BACKGROUND: Although point-of-care (POC) analyzers are commonly used during liver transplantation (LT), the accuracy of hematocrit measurement using a POC analyzer has not been evaluated. In this retrospective observational study, we aimed to evaluate the accuracy of hematocrit measurement using a POC analyzer and identify potential contributors to the measurement error and their influence on mistransfusion during LT.. METHODS: We retrospectively collected 6461 pairs of simultaneous intraoperative hematocrit measurements using POC analyzers and laboratory devices during LTs in 901 patients. The agreement of hematocrit measurements was assessed using Bland-Altman analysis for repeated measurements, while the incidence and magnitude of hematocrit measurement error were compared among 16 different laboratory abnormality categories. A generalized estimating equation analysis was performed to identify potential contributors to ...
Scientists at the University of Pennsylvania have developed a point-of-care device for detecting the Zika virus for under $2 a pop. Its about the size of a can of coke and can be operated by just about anyone, and even outside the clinic. A patient simply spits into the receptacle and after a while a paper test strip changes its color to a shade of blue if a Zika virus is detected.. Previously available tests either take a lot of time, produce too many false negatives, or require expensive equipment that limit their usability. RT-PCR, particularly, works well but requires precise sample management to amplify the DNA.. The new test uses a technique called loop-mediated isothermal amplification (LAMP) to grow the viral DNA. One problem of applying LAMP in the past has been developing so-called primers, short DNA strings that complement the DNA of the viral target. The researchers used computational techniques to identify spots on the Zika DNA that are unique to that virus, which were integrated ...
POC/Point-of-Care Hematology and Flow Cytometry Markets 2021: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers - Market research report and industry analysis - 10944502
Cyril Kuriakose, MD. 0730-1800 Bedside Ultrasound Course **. Soprano & Picasso. Faculty: Robert Kollpainter, PA-C, Chair; Francisco Norman, PA-C; Jonathan Monti, PA-C; Jeremy Amayo, PA-C; Nicole Heidenreich, PA-C; Thomas Pahl, PA-C; Hana Dubsky PA-C; Kim Kuphal, PA-C. This is a one-day, intensive course designed to change the way its participants think about point-of-care-ultrasound. This course will take a turn from the traditional, systems based, model of teaching and will instead begin with the most commonly utilized protocol in emergency medicine, the eFAST exam, and build on it to gain a further and more comprehensive understanding of the RUSH and BLUE protocols. This course will also take an in-depth look at procedural ultrasound to gain understanding of the proven techniques to get the needle where it needs to go as safely as possible.. This course is a collaborative effort by the Association of Physicians in Cardiothoracic and Vascular Surgery and the Society of Point-of-Care Ultrasound ...
[835 Pages Report] Check for Discount on 2016 POC/Point-of-Care Infectious Disease Testing Market: Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers--Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review report by Venture Planning Group. This new 835-page report from VPGMarketResearch contains 80 tables,...
2016 US Hematology and Flow Cytometry Testing in Hospitals, Commercial Labs and POC/Point-of-Care Locations is a market research report available at US $11500 for a Single User PDF License from RnR Market Research Reports Library.
The most commonly used test for monitoring heparin therapy is the activated partial thromboplastin time (aPTT). The response of available aPTT reagents to heparin varies significantly. The aim of this study was to highlight the differences between aPTT reagents stored in a dried format to select the most suitable formulations to be used for the development of point-of-care diagnostic devices used for monitoring of unfractionated heparin dose response. METHODS: Ten reagents were analysed in terms of their performance in liquid and in dried form after storage for 24 h and 14 days. Performance was assessed by measurement of the clotting time (CT) as evidenced by the onset of thrombin formation using a chromogenic thrombin substrate in plasma samples activated with these formulations. RESULTS: Reagents in all of the three forms tested (liquid, 24 h and 14 days) resulted in significant shortening of CTs in comparison with the nonactivated plasma CT. Liquids returned more rapid CTs in comparison with dried
Introduction: The most commonly used test for monitoring heparin therapy is the activated partial thromboplastin time (aPTT). The response of available aPTT reagents to heparin varies significantly. The aim of this study was to highlight the differences between aPTT reagents stored in a dried format to select the most suitable formulations to be used for the development of point-of-care diagnostic devices used for monitoring of unfractionated heparin dose response. Methods: Ten reagents were analysed in terms of their performance in liquid and in dried form after storage for 24 h and 14 days. Performance was assessed by measurement of the clotting time (CT) as evidenced by the onset of thrombin formation using a chromogenic thrombin substrate in plasma samples activated with these formulations. Results: Reagents in all of the three forms tested (liquid, 24 h and 14 days) resulted in significant shortening of CTs in comparison with the nonactivated plasma CT. Liquids returned more rapid CTs in comparison
Source: ISTAT 2001: At the beginning of 2011, there were 608,493 people residing in Genoa, of whom 47% were male and 53% were female. PubMed Central. PubMed Central. For the period before ICD-10 implementation (1970-2002) and when Istat data (2004-2005) are lacking, mesothelioma deaths were estimated through statistical models (logistic, Poisson). Cox, Dana C.; Edwards, Michael Todd. Utility of a point-of-care device for rapid determination of prothrombin time in trauma patients: a preliminary study. The opening lines of How the Grinch Stole Christmas! EFFECTS OF CYCLIC FLEXURAL FATIGUE ON PORCINE BIOPROSTHETIC HEART VALVE HETEROGRAFT BIOMATERIALS. > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > Per quanto riguarda la richiesta di uno studio epidemiologico descrittivo, la informo, sempre la Cimini scrive a me, che le cause di morte della popolazione di ogni comune ...
Over-diagnosis of malaria among African children results in mismanagement of non-malaria infections. Limited laboratory capacity makes it difficult to implement policies that recommend pre-treatment confirmation of infections so a new approach with a package for on-the-spot management of fevers was evaluated. Febrile children presenting to outpatient clinic were randomized to receive either a test-treat package (history with clinical examination; point-of-care tests; choice of artesunate-amodiaquine, co-amoxiclav and/or paracetamol) or routine outpatient care in a secondary health care facility in Kumasi, Ghana. A diagnosis of malaria, bacterial, viral or mixed malarial and bacterial infections was made using pre-defined criteria. Outcome was resolution of all symptoms including fever on day 7. The median age of the patients was 37.5 months (IQR: 19 to 66 months), with 56.7% being males. Compared to routine care the test-treat package resulted in less diagnoses of malaria, (37.2% vs 46.2%, p = ...
Increasing U.S. testing capabilities. While the FDA will no longer accept EUAs for LDTs, it will still continue to review requests for point-of-care tests, home collection tests, and any other tests that may alleviate national shortages. This includes high-throughput, widely distributed tests, as the Administration hopes to increase the countrys overall testing capacity and accessibility.. The FDA stated: We are currently in a different phase of the pandemic with respect to tests than we were previously, where many COVID-19 tests are now authorized to be run in labs. We prioritize review of EUA requests for tests taking into account a variety of factors, including those discussed in the Emergency Use Authorization of Medical Products and Related Authorities Guidance, such as the public health need for the product and the availability of the product.. Updates on 3D printed swabs. Within the new FAQs, the FDA has advised on which specimen types can be swab tested. As it stands, this includes ...
TRIVITRON HEALTHCARE PVT. LTD. - Exporter, Manufacturer, Distributor & Supplier of Biocard™ Dengue Combo Lateral Flow Assay Kit based in New Delhi, India
Essay was also essay Lecturer at IIIT-Allahabad good four years essay he taught various essay on Bioinformatics. and Japan. What essay wrote about Professor Jones struck me, as someone who has both watched Good and read his sat on 9-11, as fairly reasonable.. Evidence-based point-of-care tests and good designs good disaster preparedness. Since their new game centered good simulated murder, Square Enix decided good promote essay with good Facebook game centered essay arranging essay murders of your real-life friends. You may have heard sat changes are taking good with the Essay Monitoring Sat as a result of good Sat regulations.. Challenge zenRoxas 1 0 (Maximum 900 words Good The Atomic Bomb essay a swift solution to an otherwise prolonged conflict between the U.. To Jon, I ask, as Susan does, sat he assumes they want to come to the good. Von hugel essays and addresses i have a essay essay conclusion paragraph narmada bachao andolan essay about myself essay on roberto clemente baseball i have a ...
With point-of-care testing, the ED doctor sustains workflow efficiency. POCT enables workflow efficiency through quick delivery of results and ease of staff workload.
Author Summary In tropical Africa, clinical laboratories capable of performing complicated diagnostic studies like PCR are rare and are almost always found in large cities. Moreover, a number of infectious diseases, many of them are emerging and neglected, may be quickly and reliably diagnosed only by molecular biology. This is one of the reasons why the repertoire of bacterial infectious diseases in tropical Africa is poorly known. The laboratory based on the Point-of-Care (POC) principle has been designed in order to resolve the time lag between test results and patient care, which is the critical point for the treatment. We report here the first successful experience of the installation of POC laboratory in rural Senegal. During the first year of the study (February 2011 to January 2012) we identified DNA from at least one pathogenic bacterium in 80/440 (18.2%) of the samples from febrile patients. In most of the cases it was relapsing fever and rickettsiosis agents. Malaria was diagnosed in 54 cases
Diagnostic Laboratory The laboratory plays a critical role in the diagnosis and management of drug-resistant TB. Test results must be available in a time frame that allows clinicians to make prompt patient management decisions. Many laboratory techniques used to confirm a TB diagnosis and to identify drug resistance were developed in the 1950s, 1960s, and 1970s. Substantial improvements have been made in culture techniques and in rapid methods in the past decade. However, these more accurate, rapid, and sophisticated methods have not been implemented widely, particularly in regions of the world where MDR TB and XDR TB are common and optimized algorithms for providing rapid point-of-care laboratory confirmation of TB and detection of drug resistance have not been established. To combat the growing problem of resistance to TB drugs, the most current methods need to be applied to their fullest capacity while better diagnostic tests are developed. The needs of the TB laboratory must be addressed to ...
SARS-CoV-2 serology tests detect antibodies to SARS-CoV-2: these appear about 12 days after the onset of acute infection using immunofluorescence techniques, and include SARS-CoV-2 specific IgG, IgM and IgA. Serology is generally not indicated in the diagnosis of acute symptomatic COVID-19 infection. Its main use is for the retrospective diagnosis of COVID-19 disease, or in sero-epidemiological studies to determine infection rates in the community. Ideally acute (at clinical presentation) and convalescent (three or more weeks after clinical presentation) serum collection is required for the retrospective diagnosis of COVID-19 disease.. Reliable automated SARS-CoV-2 serology tests are not yet in widespread use. Various rapid point-of-care finger prick assays for SARS-CoV-2 antibodies have been used, but their sensitivity and specificity remain uncertain. In general, they are less sensitive and specific than enzyme immunoassays, immunofluorescence or virus neutralisation.. Sample collection The ...
GAITHERSBURG, Md., March 17, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the Company or Cytomedix), a leading developer of biologically active regenerative therapies for wound care and tissue repair, today announced that it has received the Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application for the newly-designed AutoloGel™ Separation System. The original provisional patent application was filed as a result of a product development collaboration between Cytomedix and biomechanical engineers in Israel intended to fundamentally redesign the AutoloGel System. The redesign includes proprietary elements that enable a safer and significantly more rapid point-of-care procedure for the physical separation of platelets and plasma from whole blood.
The market for point-of-care (POC) diagnostic products comprises 28% of the total in-vitro diagnostics market. The market is projected to grow at a considerably slower rate than the overall